Direct oral anticoagulant therapy in valvular heart disease Past-Present-Future

█ Review

DOI: 10.26430/CHUNGARICA.2022.52.5.386

Authors:
Kancz Sándor
Gottsegen György Országos Kardiovaszkuláris Intézet, Budapest

Summary

In the following article we are about to summarize the role of the direct oral anticoagulants in the treatment of patients with valvular heart disease. We present the data their use and the current guidelines are based on, and give some future prospect about their potential role in this patient population.

ISSUE: CARDIOLOGIA HUNGARICA | 2022 | VOLUME 52, ISSUE 5